← Open Payments lookup

THOMAS FIRNBERG: Open Payments

NPI 1164597472 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,167 in 85 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $110 · 2025 $3,167

Food & beverage: $3,167
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.28$885
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$756
Alkermes, Inc.5$367
Vanda Pharmaceuticals Inc.5$295
Janssen Pharmaceuticals, Inc3$245
E.R. Squibb & Sons, L.L.C.7$216
Lundbeck LLC7$143
Eisai Inc.1$122
Teva Pharmaceuticals USA, Inc.1$122
Otsuka Pharmaceutical Development & Commercialization, Inc.1$18

Products named: REXULTI, CAPLYTA, FANAPT, INVEGA SUSTENNA, LYBALVI, COBENFY, ABILIFY MAINTENA, ARISTADA.

Industry payments across CA — which companies pay providers there.